Achilles Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Hedge Funds | 2,102,792 | 5.12% |
| Individual Insiders | 2,676,810 | 6.52% |
| Institutions | 4,721,779 | 11.5% |
| VC/PE Firms | 13,476,959 | 32.8% |
| General Public | 18,104,608 | 44.1% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 11,086,909 | US$8.7m | 0% | 2.46% | |||
| 2,390,050 | US$1.9m | 0% | 0.29% | |||
| 2,102,792 | US$1.6m | -17.8% | 0.02% | |||
| 1,608,089 | US$1.3m | 0% | 0.05% | |||
| 1,413,809 | US$1.1m | 0% | no data | |||
| 1,112,325 | US$869.6k | 16.2% | no data | |||
| 755,375 | US$590.6k | -74.9% | 0.02% | |||
| 560,137 | US$437.9k | 4.54% | no data | |||
| 498,995 | US$390.1k | 14.1% | no data | |||
| 461,835 | US$361.1k | 23.7% | no data | |||
| 269,600 | US$210.8k | 41.6% | no data | |||
| 226,250 | US$176.9k | -6.22% | no data | |||
| 108,454 | US$84.8k | 88.2% | no data | |||
| 108,083 | US$84.5k | 0% | 0.01% | |||
| 76,269 | US$59.6k | -2.43% | 0.03% | |||
| 46,663 | US$36.5k | 0% | no data | |||
| 39,593 | US$31.0k | 0% | no data | |||
| 30,949 | US$24.2k | 90.1% | no data | |||
| 22,592 | US$17.7k | -69.2% | no data | |||
| 21,590 | US$16.9k | 0% | no data | |||
| 17,900 | US$14.0k | 0% | no data | |||
| 14,539 | US$11.4k | 0% | no data | |||
| 2,425 | US$1.9k | 0% | no data | |||
| 2,000 | US$1.6k | -33.3% | no data | |||
| 989 | US$774.1 | 0% | no data |